Insmed Inc shares rise after positive Phase 3b ENCORE results. The stock shows strength, trading above its 20-day moving average despite earlier fluctuations.
Mar 23
at
9:43 PM
Relevant people
Log in or sign up
Join the most interesting and insightful discussions.